Cagrilintide 5mg
GLP-1 / Weight LossA long-acting amylin analog that locks in fullness - the go-to stack partner for GLP-1 users.
science
Standard Reference Dosing
Vial Strength
5mg
BAC Water
2mL
Dose / Injection
0.25mg
Schedule
Weekly
Typical Cycle
Usually run alongside a GLP-1 for 12+ weeks; rarely used alone long-term.
Draw Amount
10 units
Community Reported Benefits
- Triggers deep, lasting satiety by acting directly on brain appetite centers - meals feel bigger than they are.
- Stacked with semaglutide or tirzepatide, users report noticeably stronger appetite control than either compound alone.
- Slows gastric emptying so food sits longer, killing the urge to snack between meals.
Things to Watch For
- Nausea, especially when combined with a GLP-1
- Reduced appetite that can be pronounced when stacked
- Mild injection site reactions
schedule Best Time to Take (Community Consensus)
Morning or evening, often taken alongside GLP-1 dose.
Mechanism of Action
A long-acting amylin analog that binds amylin receptors in the brainstem, extending the feeling of fullness well beyond what GLP-1 alone produces.
Technical Reference
Half-life
~7 days
Mol. Weight
~4,409 g/mol
ac_unit Storage & Handling
Keep refrigerated before and after mixing; use the reconstituted vial within 30 days.
Reconstitution steps & injection technique arrow_forward
Compiled from community-reported research protocols for informational purposes. Not medical advice. Consult a licensed physician before starting any research or personal protocol.